Targeted drug, radiotherapy could prolong life of liver canc

Chinese University researchers say patients in trial took oral targeted therapy once a day and underwent scans every six weeks.

Related Keywords

Hong Kong , South Korea , China , Chinese , Stephen Chan , Chinese University , Landon Chan Long , Liver Cancer , Immunotherapy , Targeted Therapy , Radiotherapy , Cabozantinib , Dancer , Chan Lam , Chinese University Of Hong Kong , Liver , Medication , Ncology , Patients , Researchers , Stephen Chan Lam , Treatment ,